NADAV FRIEDMANN - 31 Dec 2022 Form 5 Insider Report for CASSAVA SCIENCES INC (SAVA)

Role
Chief Medical Officer, Director
Signature
/s/ Eric J. Schoen - Chief Financial Officer
Issuer symbol
SAVA
Transactions as of
31 Dec 2022
Transactions value $
$0
Form type
5
Filing time
03 Jan 2023, 15:16:47 UTC
Previous filing
03 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAVA Common Stock Gift $0 -10 -0.01% $0.00 79.9K 31 Jan 2022 Direct F1
transaction SAVA Common Stock Gift $0 -990 -1.24% $0.00 78.9K 15 Mar 2022 Direct F1
holding SAVA Common Stock 143 31 Dec 2022 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona Fide Gift